Schrodinger has won U.S. Food and Drug Administration fast-track designation for its SGR-1505 drug candidate in a rare type of non-Hodgkin's lymphoma.

President Donald Trump’s approval rating is underwater, and a majority of voters believe the country is on the wrong track, ...